Medtronic (MDT) Restructuring Costs (2013 - 2026)

Medtronic has disclosed Restructuring Costs across 14 years of filings, most recently posting $77.0 million for Q1 2026.

• Restructuring Costs for Q1 2026 came in at $77.0 million, up 79.07% year-over-year; the trailing twelve-month figure through Jan 2026 was $282.0 million (down 35.17% YoY), and the FY2025 annual result was $267.0 million, up 18.14% from the prior year.
• Restructuring Costs came in at $77.0 million for Q1 2026 at Medtronic, up from $13.0 million in the prior quarter.
• In the past five years, Restructuring Costs ranged from a high of $300.0 million in Q2 2023 to a low of $13.0 million in Q4 2025.
• The 5-year median for Restructuring Costs is $62.0 million (2024), against an average of $93.2 million.
• Across the five-year window, Restructuring Costs surged 550.0% in 2023 and slumped 56.67% in 2025, its largest moves.
• Medtronic's Restructuring Costs stood at $30.0 million in 2022, then surged by 33.33% to $40.0 million in 2023, then declined by 25.0% to $30.0 million in 2024, then plunged by 56.67% to $13.0 million in 2025, then surged by 492.31% to $77.0 million in 2026.
• The last three Restructuring Costs figures came in at $77.0 million (Q1 2026), $13.0 million (Q4 2025), and $45.0 million (Q3 2025), per Business Quant data.